Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Mylan personnel appointments

Executive Summary

VP-Generic Business Development John Deiriggi is appointed to the new position of chief operating officer of Mylan's generic subsidiary, Mylan Pharmaceuticals, the company announces. Deiriggi is a 19-year veteran of Mylan. In connection with the promotion, Exec Director of Corporate Administration Daniel Caron will take over as VP of generic business development. Additional moves include Gary Sphar to the post of exec VP and CFO of Mylan Pharmaceuticals and Brian Roman to the post of VP and general counsel of the generic subsidiary...
Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS046492

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel